Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials

Takao Ohki, Hiroyoshi Yokoi, Kimihiko Kichikawa, Takeshi Kimura, Scott A. Snyder, Anthony O. Ragheb, Erin E. O'Leary, Michael R. Jaff, Gary M. Ansel, Michael D. Dake

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint Dive into the research topics of 'Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences